Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Hold the syringe or pen in your dominant hand
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Distributed through LillyDirect 's self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand
These studies have shown promising effects on tissue repair, blood vessel formation, and inflammation regulation
Draw to the line between 12 and 13 units
US$ 25.73
US$ 26.65
US$ 26.36
US$ 28.42
